Richard Evans, a CF scientist at Inspire Pharmaceuticals, will be remembered for his contributions to CF research.
This past March, the CF community lost a dedicated scientist working at the forefront of CF research when Richard Evans, Ph.D., died suddenly while on a business trip in Spain. A leading scientist at Inspire Pharmaceuticals, Evans was part of a team working to develop denufosol, a potential CF drug now in Phase 3 clinical trials. Evans joined Inspire in 1996 shortly after the company opened its doors and had served as vice president of pharmaceutical development since June of 2000.
Following his death, the CF Foundation has received nearly $27,000 in memorial contributions. In addition, the Carolinas Chapter recently dedicated its Master Chef’s Dinner in memory of Evans, who was a regular attendee since the event began in 1996. Inspire became a presenting sponsor of this event in 1997.
“Richard’s life continues to provide motivation for the Inspire team to work closely with the CF community, especially the CF Foundation, to achieve important progress in the treatment of CF,” said Christy Shaffer, Ph.D., Inspire president and CEO. “He will be remembered at Inspire and throughout the pharmaceutical industry for his knowledge, hard work, integrity and compassion for others.”